October😎🌶️

Agree

What happened to editorial.board of JACC Journals ? They recently publish questionable trials in terms of validity and ethics.

Atrial fibrillation is often a metabolic disease. Aggressive modification of obesity and metabolic risk factors up front will reduce the need for ablation.

Antidepressants show distinct physiological effects. Meta-analysis of 151 RCTs (58,534 pts): Nortriptyline and doxepin increase BP and HR. Paroxetine, duloxetine, venlafaxine, and desvenlafaxine raise cholesterol and glucose. Duloxetine and desvenlafaxine elevate liver enzymes.

Walking boosts creative thinking. A moving body is a moving mind.

It is all about business!

Interesting, and expected.

Okaaaay! Exercise improve both sleep onset and quality, but do not do them too late.

We’re launching a research mentorship program where you’ll learn meta-analysis from A to Z. Get hands-on tasks, full feedback, and join a real research project with full guidance until publication. 🔴limited to 20 participants to ensure proper follow-up details: +20 122 799 9117

The research rubbish

How?????

🎓 REACH: The Research-to-Publication Workshop. A personalized mentorship for you. Limited seats: Only 20 seats. Get your first publication. For more details, send us a message via WhatsApp: +201227999117

These are the health influencers who kill patients with their hot takes. They take a small, well-documented rise in glucose metabolism that tips a sub-set of patients already near a diabetes diagnosis into type 2 diabetes and proclaim that statins “destroy your metabolism,” while

Semaglutide versus caloric restriction-induced weight loss: insights into effects on skeletal muscle mass and function "...suggests that the loss of muscle function and mass during treatment is not unique to GLP-1RA pharmacology but rather reflects the biology of caloric

📢:Registration closes in one week ⏳⏳

يا ريت الرجالة تبطل طاقة سلبية وعواء، ركز في حاجة واجتهد فيها وربنا بيكرم

انا لازم أجيب قط شرازى خلاص مفيش مفر